Patent-linkage system is controversial

The country’s pharmaceutical companies face tough times ahead with the new Korea-U.S. Free Trade Agreement poised to strengthen patent rights for U.S. drug giants, heaping strain on the generic-focused Korean industry

Under the agreement, the two countries agreed to upgrade intellectual property protection, tackle the lack of transparency in Korea’s health care system and combat unethical bu...